- ►rupress.org [PDF] SI Staprans, BL Hamilton, SE Follansbee, T … - Journal of Experimental Medicine, 1995 - jem.rupress.org Summary Little is known about the factors that govern the level of HIV-1
replication in infected individ- uals. Recent studies (using potent antiviral
drugs) of the kinetics of HIV-1 replication in vivo have demonstrated that ... Cited by 273 - Related articles - BL Direct - All 3 versions
T Schacker, J Zeh, H Hu, M Shaughnessy, L … - The Journal of infectious diseases, 2002 - UChicago Press Featured in US News & World Report "Common Cold Virus Alters Body's Genes"
October 24, 2008 Comparison of the Safety and Immunogenicity of 2 Respiratory
Syncytial Virus (RSV) Vaccines— Nonadjuvanted Vaccine or Vaccine ... Cited by 97 - Related articles - BL Direct - All 5 versions
MJ Glesby, DR Hoover, S Weng, NMH Graham, … - The Journal of infectious diseases, 1996 - jstor.org Use of Antiherpes Drugs and the Risk of Kaposi's Sarcoma: Data from the ...
Marshall J. Glesby, Donald R. Hoover, Shigui Weng, Neil MH Graham, John P.
Phair, Roger Detels, Monto Ho, and Alfred J. Saah Cited by 88 - Related articles - BL Direct - All 3 versions
MB Feinberg - Lancet, 1996 - ph.ucla.edu Since the initial reports of AIDS 15 years ago, our understanding of the disease
process and the behaviour of the aetiological agent, the human immunodeficiency
virus (HIV), have advanced substantially. Sensitive tools are now available ... Cited by 87 - Related articles - View as HTML - BL Direct - All 3 versions
MJ Glesby, DR Hoover - Annals of internal medicine, 1996 - Am Coll Physicians Unlike patients in a randomized, clinical trial, patients in an observational
study choose if and when to begin treatment. Patients who live longer have more
opportunities to select treatment; those who die earlier may be untreated ... Cited by 86 - Related articles - BL Direct - All 4 versions
JPA Ioannidis, AC Collier, DA Cooper, L … - The Journal of infectious diseases, 1998 - UChicago Press Page 1. 349 Clinical Efficacy of High-Dose Acyclovir in Patients with Human
Immunodeficiency Virus Infection: A Meta-Analysis of ... Cited by 71 - Related articles - BL Direct - All 4 versions
- ►lancs.ac.uk [PDF] JE Feinberg, S Hurwitz, D Cooper, FR Sattler … - The Journal of Infectious Diseases, 1998 - UChicago Press Page 1. 48 A Randomized, Double-Blind Trial of Valaciclovir Prophylaxis
for Cytomegalovirus Disease in Patients with Advanced Human ... Cited by 51 - Related articles - BL Direct - All 5 versions
A Dasgupta, PC Okhuysen - Therapeutic drug monitoring, 2001 - pdfs.journals.lww.com Summary: A variety of medications are used in treating patients infected with
the human immunodeficiency virus (HIV). These medications are used to control
viremia and to prevent and treat opportunistic infections. An individual is ... Cited by 43 - Related articles - BL Direct - All 8 versions
EG Apolonio, DR Hoover, Y He, AJ Saah, DW … - The Journal of Infectious Diseases, 1995 - jstor.org Prognostic Factors in Human Immunodeficiency Virus-Positive Patients with a ...
Elizabeth G. Apolonio, Donald R. Hoover, Yanhua He, Alfred J. Saah, David W.
Lyter, Roger Detels, Richard A. Kaslow, and John P. Phair Cited by 38 - Related articles - BL Direct - All 2 versions
- ►annals.org NMH Graham, DR Hoover, LP Park, DS Stein, … - Annals of internal medicine, 1996 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Background: Among patients who begin receiving zidovudine during ... Cited by 34 - Related articles - BL Direct - All 4 versions
